Key result
Early ICDs show no mortality benefit in post-STEMI patients with impaired LVEF and inducible VT.
Why the study?
Methods to identify high-risk patients and the optimal timing of ICD therapy after ST-elevation myocardial infarction require further optimization.
Does early risk stratification with EPS and targeted ICD implantation reduce total mortality in patients with STEMI treated with primary PCI?
Cohort (n=689)
Does early risk stratification with EPS and targeted ICD implantation reduce total mortality in patients with STEMI treated with primary PCI?
Early risk stratification using EPS to guide targeted ICD implantation in STEMI patients with LVEF ≤40% achieves low mortality rates comparable to patients with preserved LVEF.
Answers are grounded in this paper and cite their sources.
Early ICD was not linked to lower mortality in this cohort; leaves open whether RCTs are needed to guide post-STEMI decisions.
BACKGROUND: Methods to identify high-risk patients and timing of implantable cardioverter-defibrillator (ICD) therapy after ST-elevation myocardial infarction need further optimization. METHODS AND RESULTS: We evaluated outcomes of early ICD implantation in patients with inducible ventricular tachycardia. Consecutive patients treated with primary percutaneous coronary intervention for acute ST-elevation myocardial infarction underwent early left ventricular ejection fraction (LVEF) assessment. Patients with LVEF >40% were discharged (group 1); patients with LVEF < or =40% underwent risk stratification with electrophysiological study. If no ventricular tachycardia was induced, patients were discharged without an ICD (group 2). If sustained monomorphic ventricular tachycardia (> or =200-ms cycle length) was induced, an ICD was implanted before discharge (group 3). Follow-up was obtained up to 30 months in all patients and up to 48 months in a subgroup of patients with LVEF < or =30% without an ICD. The primary end point was total mortality. Group 1 (n=574) had a mean LVEF of 54+/-8%; group 2 (n=83), 32+/-6%; and group 3 (n=32), 29+/-7%. At a median follow-up of 12 months, there was no significant difference in survival between the 3 groups (P=0.879), with mortality rates of 3%, 3%, and 6% for groups 1 through 3, respectively. In the subgroup of group 2 patients with LVEF < or =30% and no ICD (n=25), there was 9% mortality at a median follow-up of 25 months. In group 3, 19% had spontaneous ICD activation resulting from ventricular tachycardia. CONCLUSIONS: Early ICD implantation limited to patients with inducible ventricular tachycardia enables a low overall mortality in patients with impaired LVEF after primary percutaneous coronary intervention for ST-elevation myocardial infarction.
No takes yet. Share an insight, caveat, or question.
Zaman et al. (2009) conducted a cohort in acute ST-elevation myocardial infarction (n=689). Early ICD implantation for inducible ventricular tachycardia vs. No ICD was evaluated on total mortality (p=0.879). Early ICD implantation for post-STEMI patients with impaired LVEF and inducible ventricular tachycardia yielded a 6% mortality rate, similar to patients without ICDs.
Synapse has enriched 10 related papers. Consider them for comparative context: